SwiftTrial's profile picture. SWIFT DIRECT: The international, multicentre, randomised-controlled trial for bridging thrombolysis versus direct mechanical thrombectomy in patients with LVO

SWIFT DIRECT Trial

@SwiftTrial

SWIFT DIRECT: The international, multicentre, randomised-controlled trial for bridging thrombolysis versus direct mechanical thrombectomy in patients with LVO

SWIFT DIRECT Trial 已轉發

🧠You can still register for the #WSC2025 Highlights Webinar — hosted by ESO, @WorldStrokeOrg and @American_Stroke. Get key updates in stroke research & care. 🔗us02web.zoom.us/webinar/regist… #Stroke #StrokeScience #StrokeEducation #Neurology @SposatoL @eva_mistry @jeyaraj_pandian

ESOstroke's tweet image. 🧠You can still register for the #WSC2025 Highlights Webinar — hosted by ESO, @WorldStrokeOrg and @American_Stroke. Get key updates in stroke research & care. 🔗us02web.zoom.us/webinar/regist…
#Stroke #StrokeScience #StrokeEducation #Neurology @SposatoL @eva_mistry @jeyaraj_pandian

SWIFT DIRECT Trial 已轉發

📣 Calling all stroke specialists in Latin America! Join us in São Paulo, Dec 2–5 2025, for the first Latin America Stroke Summer School from University of Bern in partnership with Rede Brasil AVC and ESO, endorsed by WSO. 🎥 Check out Urs Fischer’s invitation and get ready for…


SWIFT DIRECT Trial 已轉發

🔊 Exciting DO-IT Trial Update!🔊 📈 🌍 The trial continues to expand, with 23 sites actively recruiting across Europe and 30 patients enrolled so far! 👏 A big thank you to everyone contributing! 💉🧑‍⚕️Recruit. Care. Cure. DO-IT!

DOIT_trial's tweet image. 🔊 Exciting DO-IT Trial Update!🔊
📈 🌍 The trial continues to expand, with 23 sites actively recruiting across Europe and 30 patients enrolled so far!
👏 A big thank you to everyone contributing!
💉🧑‍⚕️Recruit. Care. Cure. DO-IT!

SWIFT DIRECT Trial 已轉發

In anterior circulation stroke patients post-thrombectomy, low and medium doses of intra-arterial tenecteplase demonstrated adequate safety to warrant larger trials to investigate their therapeutic potential. ja.ma/47ZpZBx

JAMANeuro's tweet image. In anterior circulation stroke patients post-thrombectomy, low and medium doses of intra-arterial tenecteplase demonstrated adequate safety to warrant larger trials to investigate their therapeutic potential. ja.ma/47ZpZBx

SWIFT DIRECT Trial 已轉發

Join us in Maastricht, 6–8 May 2026! #ESOC2026 will take place in one of Europe’s most historic cities, bringing together leading voices in #stroke science&care. Experience three days of world-class research, education&collaboration: eso-stroke.org/esoc2026/ #VoiceOfStroke

ESOstroke's tweet image. Join us in Maastricht, 6–8 May 2026!
#ESOC2026 will take place in one of Europe’s most historic cities, bringing together leading voices in #stroke science&care.
Experience three days of world-class research, education&collaboration: eso-stroke.org/esoc2026/
#VoiceOfStroke

SWIFT DIRECT Trial 已轉發

🚨 TECNO trial update 🚨 131 patients enrolled! Only 25 more to hit our target of 156 - the final countdown is on 🏁 We sincerely thank all the centers and investigators on their efforts! 💪 #TECNO 💿

TECNO_Trial's tweet image. 🚨 TECNO trial update 🚨 131 patients enrolled! Only 25 more to hit our target of 156 - the final countdown is on 🏁 We sincerely thank all the centers and investigators on their efforts! 💪
#TECNO 💿

SWIFT DIRECT Trial 已轉發

In patients with supratentorial intracerebral hemorrhage, minimally invasive surgery within 72 hours did not significantly reduce 30-day mortality or improve 180-day disability compared to medical management alone. ja.ma/3VtSrUo

JAMANeuro's tweet image. In patients with supratentorial intracerebral hemorrhage, minimally invasive surgery within 72 hours did not significantly reduce 30-day mortality or improve 180-day disability compared to medical management alone. ja.ma/3VtSrUo

SWIFT DIRECT Trial 已轉發
StrokeSchool's tweet image. Register now: neurorad.insel.ch/de/lehre-und-f…

SWIFT DIRECT Trial 已轉發

Neurology Podcast: Dr. Dan Ackerman and Dr. Urs Fischer discuss the optimal timing of anticoagulation after ischemic #stroke in patients with #AtrialFibrillation. Listen now: hubs.la/Q03DtG2J0 #NeuroTwitter @DrDanAckerman



SWIFT DIRECT Trial 已轉發

Many thanks for the opportunity to discuss the CATALYST meta-analysis and our ongoing trials (ELAPSE and DO IT). @BoNorrving @SignildAsberg @DavidSeiffge @TotoMynell @unibern

Neurology Podcast: Dr. Dan Ackerman and Dr. Urs Fischer discuss the optimal timing of anticoagulation after ischemic #stroke in patients with #AtrialFibrillation. Listen now: hubs.la/Q03DtG2J0 #NeuroTwitter @DrDanAckerman



SWIFT DIRECT Trial 已轉發

I have been invited to talk about our CATALYST meta-analysis in the ‚Neurology Podcast‘. Press the button below and find out more on CATALYST, but also on our ELAPSE and DO IT trials. ⁦@BoNorrving⁩ ⁦@SignildAsberg⁩ ⁦@SeiffgeDavid directory.libsyn.com/episode/index/…

FishingNeurons's tweet card. Optimal Timing of Anticoagulation After Ischemic Stroke and Atrial...

directory.libsyn.com

Optimal Timing of Anticoagulation After Ischemic Stroke and Atrial...


SWIFT DIRECT Trial 已轉發

🧠❄️ Level up your stroke skills! The 13th ESO–ESMINT–ESNR Stroke Winter School offers young #stroke physician or neuroradiologist an unparalleled training experience. Apply until 30 September🔗 ow.ly/etWk50WECke #StrokeCare #StrokeEducation @inselgruppe

ESOstroke's tweet image. 🧠❄️ Level up your stroke skills!
The 13th ESO–ESMINT–ESNR Stroke Winter School offers young #stroke physician or neuroradiologist an unparalleled training experience.
Apply until 30 September🔗 ow.ly/etWk50WECke
#StrokeCare #StrokeEducation @inselgruppe

SWIFT DIRECT Trial 已轉發

Mark your calendars now! 📅 Save the Date: 6-8 May 2026, #ESOC2026 in Maastricht We can't wait to bring you more details this autumn, so stay tuned for updates!🔗 eso-stroke.org/esoc2026/ #Neurology #Stroke #VoiceOfStroke

ESOstroke's tweet image. Mark your calendars now! 📅 Save the Date: 6-8 May 2026,  #ESOC2026 in Maastricht
 We can't wait to bring you more details this autumn, so stay tuned for updates!🔗 eso-stroke.org/esoc2026/
#Neurology #Stroke #VoiceOfStroke

SWIFT DIRECT Trial 已轉發

Most viewed this week from @JAMANeuro: Compared with endovascular treatment (EVT) alone, intravenous thrombolysis plus EVT modestly increased the risk of intracranial hemorrhage, notably any parenchymal hematoma. ja.ma/3JyZHLW

JAMANeuro's tweet image. Most viewed this week from @JAMANeuro: 

Compared with endovascular treatment (EVT) alone, intravenous thrombolysis plus EVT modestly increased the risk of intracranial hemorrhage, notably any parenchymal hematoma. 

ja.ma/3JyZHLW

SWIFT DIRECT Trial 已轉發

🚨 Registration for Stroke Winter School 2026 is NOW OPEN! 🚨 Join stroke physicians and neuroradiologists in an exclusive course designed to boost interdisciplinary stroke care. Don’t miss out—secure your spot today! @ESOstroke @esmintsociety @ESNRad


SWIFT DIRECT Trial 已轉發

Dr Costru-Tașnic reflects on her inspiring journey as part of the 2024–2026 European Stroke Master Programme in Bern, supported by an ESO scholarship. She brings fresh ideas to improve stroke care in Moldova. 🔗eso-stroke.org/eso-scholarshi… 📣 Apply: ow.ly/rQlo50Wghnh #Stroke

ESOstroke's tweet image. Dr Costru-Tașnic reflects on her inspiring journey as part of the 2024–2026 European Stroke Master Programme in Bern, supported by an ESO scholarship. She brings fresh ideas to improve stroke care in Moldova.

🔗eso-stroke.org/eso-scholarshi…
📣 Apply: ow.ly/rQlo50Wghnh

#Stroke

SWIFT DIRECT Trial 已轉發

📝 Our meta-analysis, published in Annals of Neurology, shows IA thrombolysis after LVO successful thrombectomy ↑ odds of excellent 90-day recovery with no ↑ odds of sICH or death. @PittStroke @RaulNogueiraMD @Mahmoudneuro @Ammarjumah4 @NguyenThanhMD 🔗 onlinelibrary.wiley.com/doi/10.1002/an…

fahmy_doheim's tweet image. 📝 Our meta-analysis, published in Annals of Neurology, shows IA thrombolysis after LVO successful thrombectomy ↑ odds of excellent 90-day recovery with no ↑ odds of sICH or death. @PittStroke @RaulNogueiraMD @Mahmoudneuro @Ammarjumah4 @NguyenThanhMD 
🔗 onlinelibrary.wiley.com/doi/10.1002/an…

SWIFT DIRECT Trial 已轉發

Does intravenous thrombolysis prior endovascular treatment (EVT) increases the risk of intracranial haemorhage compared to EVT alone? Check our latest article in JAMA Neurology! @StrokeBern @CheesemakerMD @fabianoca @kiliantreurniet @manonkappelhof @TotoMynell

Compared with endovascular treatment (EVT) alone, intravenous thrombolysis plus EVT modestly increased the risk of intracranial hemorrhage, notably any parenchymal hematoma. ja.ma/47hoEFu

JAMANeuro's tweet image. Compared with endovascular treatment (EVT) alone, intravenous thrombolysis plus EVT modestly increased the risk of intracranial hemorrhage, notably any parenchymal hematoma. ja.ma/47hoEFu


SWIFT DIRECT Trial 已轉發

Better secondary prevention strategies beyond (D)OACs are needed - combining DOAC with LAAO might be an option jamanetwork.com/journals/jaman… RCT ongoing —> @ELAPSETrial @StrokeBern @FishingNeurons @TotoMynell


SWIFT DIRECT Trial 已轉發

The Upshot: When a patient with AF has a stroke on a DOAC, don’t switch to warfarin. The result will be a higher risk of recurrent stroke and ICH down the road Anticoagulation Strategies Following Breakthrough Ischemic Stroke While on DOACs neurology.org/doi/10.1212/WN…


Loading...

Something went wrong.


Something went wrong.